National Philanthropic Trust’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.95M Buy
7,742
+668
+9% +$144K 0.03% 177
2026
Q1
$1.54M Sell
7,074
-176
-2% -$39K 0.02% 180
2025
Q4
$1.66M Buy
7,250
+2,395
+49% +$546K 0.02% 181
2025
Q3
$1.12M Buy
4,855
+762
+19% +$155K 0.01% 179
2025
Q2
$760K Buy
4,093
+974
+31% +$181K 0.01% 194
2025
Q1
$653K Buy
3,119
+369
+13% +$71.7K 0.01% 186
2024
Q4
$489K Sell
2,750
-26
-0.9% -$4.78K 0.01% 213
2024
Q3
$548K Sell
2,776
-159
-5% -$29.7K 0.01% 188
2024
Q2
$503K Sell
2,935
-960
-25% -$159K 0.01% 196
2024
Q1
$709K Sell
3,895
-2,016
-34% -$347K 0.02% 180
2023
Q4
$916K Buy
+5,911
New +$862K 0.02% 167

Other funds holding ABBV

National Philanthropic Trust's ABBV Position: Q2 2026 in Review

National Philanthropic Trust increased its AbbVie (ABBV) stake by 9.4% in Q2 2026, buying an estimated $144K and bringing the position to 7,742 shares worth $1.95M. The position accounts for 0.03% of the portfolio, ranked #177.

National Philanthropic Trust first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,063 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • National Philanthropic Trust held 7,742 shares of AbbVie worth $1.95M as of Q2 2026.
  • National Philanthropic Trust bought 668 AbbVie shares in Q2 2026, an estimated $144K.
  • AbbVie made up 0.03% of National Philanthropic Trust's portfolio in Q2 2026, its #177 holding.
  • National Philanthropic Trust first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,063 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on National Philanthropic Trust's 13F filing for Q2 2026, filed 14 Aug 2026.